Tumor budding is an independent predictor of outcome in AJCC/UICC stage II colorectal cancer

Annals of Surgical Oncology

Volumn 19, Issue 12, 2012, Pages 3706-3712

  Betge, Johannes ^a   Kornprat, Peter ^a   Pollheimer, Marion J ^a   Lindtner, Richard A ^a   Schlemmer, Andrea ^a   Rehak, Peter ^a   Vieth, Michael ^b   Langner, Cord ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b INSTITUTE OF PATHOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; FEMALE; HUMAN; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT COUNSELING; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; TUMOR GROWTH; TUMOR LOCALIZATION; TUMOR VOLUME;

ADENOCARCINOMA; ADENOCARCINOMA, MUCINOUS; ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 84868141776     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-012-2426-z     Document Type: Article

References (34)

1. Compton CC. Optimal pathologic staging: defining stage II disease. Clin Cancer Res. 2007;13:6862-70.
2. McLeod HL, Murray GI. Tumour markers of prognosis in colorectal cancer. Br J Cancer. 1999;79:191-203. (Pubitemid 29002285)
3. Lyall MS, Dundas SR, Curran S, Murray GI. Profiling markers of prognosis in colorectal cancer. Clin Cancer Res. 2006;12: 1184-91. (Pubitemid 43342507)
4. Jass JR, Atkin WS, Cuzick J, et al. The grading of rectal cancer: historical perspectives and a multivariate analysis of 447 cases. Histopathology. 1986;10:437-59. (Pubitemid 16039125)
5. Jass JR, Love SB, Northover JM. A new prognostic classification of rectal cancer. Lancet. 1987;1:1303-6. (Pubitemid 17072200)
6. Ueno H, Murphy J, Jass JR, Mochizuki H, Talbot IC. Tumour "budding" as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology. 2002;40:127-32. (Pubitemid 34122114)
7. Hase K, Shatney C, Johnson D, Trollope M, Vierra M. Prognostic value of tumor "budding" in patients with colorectal cancer. Dis Colon Rectum. 1993;36:627-35. (Pubitemid 23206317)
8. Prall F. Tumour budding in colorectal carcinoma. Histopathology. 2007;50:151-62. (Pubitemid 44953405)
9. Moertel CG, Fleming TR, Macdonald JS, et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med. 1990;322:352-8. (Pubitemid 20042739)
10. Sobin L, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumors. 7th edition. West Sussex: Wiley-Blackwell; 2010.
11. Hamilton SR, Bosman FT, Boffetta P, et al. Carcinoma of the colon and rectum. In: Bosman FT, Carneiro F, Hruban RH, Theise ND, editors. World Health Organization classification of tumours of the digestive system. Lyon: IARC; 2010. p. 131-81.
12. Kanazawa H, Mitomi H, Nishiyama Y, et al. Tumour budding at invasive margins and outcome in colorectal cancer. Colorectal Dis. 2008;10:41-7. (Pubitemid 350238562)
13. Zlobec I, Terracciano L, Tornillo L, et al. Role of RHAMM within the hierarchy of well-established prognostic factors in colorectal cancer. Gut. 2008;57:1413-9.
14. Ueno H, Price AB, Wilkinson KH, Jass JR, Mochizuki H, Talbot IC. A new prognostic staging system for rectal cancer. Ann Surg. 2004;240:832-9. (Pubitemid 39425776)
15. Okuyama T, Nakamura T, Yamaguchi M. Budding is useful to select high-risk patients in stage II well-differentiated or moderately differentiated colon adenocarcinoma. Dis Colon Rectum. 2003;46:1400-6. (Pubitemid 37267636)
16. Choi DH, Sohn DK, Chang HJ, Lim SB, Choi HS, Jeong SY. Indications for subsequent surgery after endoscopic resection of submucosally invasive colorectal carcinomas: a prospective cohort study. Dis Colon Rectum. 2009;52:438-45.
17. Ohtsuki K, Koyama F, Tamura T, et al. Prognostic value of immunohistochemical analysis of tumor budding in colorectal carcinoma. Anticancer Res. 2008;28:1831-6. (Pubitemid 351892892)
18. Shepherd NA, Saraga EP, Love SB, Jass JR. Prognostic factors in colonic cancer. Histopathology. 1989;14:613-20. (Pubitemid 19157929)
19. Cianchi F, Messerini L, Palomba A, et al. Character of the invasive margin in colorectal cancer: does it improve prognostic information of Dukes staging? Dis Colon Rectum. 1997;40: 1170-6.
20. Roncucci L, Fante R, Losi L, et al. Survival for colon and rectal cancer in a population-based cancer registry. Eur J Cancer. 1996;32A:295-302.
21. Ueno H, Jones A, Jass JR, Talbot IC. Clinicopathological significance of the "keloid-like" collagen and myxoid stroma in advanced rectal cancer. Histopathology. 2002;40:327-34. (Pubitemid 34595582)
22. Cianchi F, Messerini L, Comin CE, et al. Pathologic determinants of survival after resection of T3N0 (stage IIA) colorectal cancer: proposal for a new prognostic model. Dis Colon Rectum. 2007; 50:1332-41. (Pubitemid 47472384)
23. Zlobec I, Baker K, Minoo P, Hayashi S, Terracciano L, Lugli A. Tumor border configuration added to TNM staging better stratifies stage II colorectal cancer patients into prognostic subgroups. Cancer. 2009;115:4021-9.
24. Nakamura T, Mitomi H, Kanazawa H, Ohkura Y, Watanabe M. Tumor budding as an index to identify high-risk patients with stage II colon cancer. Dis Colon Rectum. 2008;51:568-72.
25. Tanaka M, Hashiguchi Y, Ueno H, Hase K, Mochizuki H. Tumor budding at the invasive margin can predict patients at high risk of recurrence after curative surgery for stage II, T3 colon cancer. Dis Colon Rectum. 2003;46:1054-9. (Pubitemid 36992987)
26. Wang LM, Kevans D, Mulcahy H, et al. Tumor budding is a strong and reproducible prognostic marker in T3N0 colorectal cancer. Am J Surg Pathol. 2009;33:134-41.
27. Prall F, Nizze H, Barten M. Tumour budding as prognostic factor in stage I/II colorectal carcinoma. Histopathology. 2005;47: 17-24. (Pubitemid 40978809)
28. Shinto E, Jass JR, Tsuda H, et al. Differential prognostic significance of morphologic invasive markers in colorectal cancer: tumor budding and cytoplasmic podia. Dis Colon Rectum. 2006; 49:1422-30. (Pubitemid 44401393)
29. Yoshida K, Yoshimatsu K, Otani T, Yokomizo H, Ogawa K. The depth of tumor invasion beyond the outer border of the muscularis propria as a prognostic factor for T3 rectal/rectosigmoid cancer. Anticancer Res. 2008;28:1773-8. (Pubitemid 351892883)
30. Okuyama T, Oya M, Ishikawa H. Budding as a useful prognostic marker in pT3 well- or moderately-differentiated rectal adenocarcinoma. J Surg Oncol. 2003;83:42-7. (Pubitemid 36528708)
31. De Quay N, Cerottini JP, Albe X, Saraga E, Givel JC, Caplin S. Prognosis in Duke's B colorectal carcinoma: the Jass classification revisited. Eur J Surg. 1999;165:588-92. (Pubitemid 29377110)
32. Sato H, Maeda K, Sugihara K, et al. High-risk stage II colon cancer after curative resection. J Surg Oncol. 2011;104:45-52.
33. Vieth M, Quirke P, Lambert R, von Karsa L, Risio M. Annex to Quirke et al. Quality assurance in pathology in colorectal cancer screening and diagnosis: annotations of colorectal lesions. Virchows Arch. 2011;458:21-30.
34. Compton CC. Colorectal carcinoma: diagnostic, prognostic, and molecular features. Mod Pathol. 2003;16:376-88. (Pubitemid 36443987)